PopulationsHumans

Generalizability of SELECT and SURMOUNT-MMO Trial Criteria to the U.S. OMM-Eligible Adult Population

ADA Scientific Sessions 2025 Abstract

The paper

Ambarish Pandey, Donna Mojdami, Carlos R. Vallarino,

Rebecca M. Fee, Noelle N. Gronroos, M. Ducharme, Ángel Rodríguez,

Chanadda Chinthammit

Dallas

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Late-breaking 2097-LB

doi.org/10.2337/db25-2097-lb

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026